USOO8058243B2 (12) United States Patent (10) Patent No.: US 8,058,243 B2 Tyers et al. (45) Date of Patent: Nov. 15, 2011 (54) METHOD FORTREATING A BRAIN CANCER Corcoran et al., “A mouse model for medulloblastoma and basal cell WITH IFENPRODIL nevus syndrome” J. Neuro-oncol., 53(3):307-318 (Jul. 2001). Dalton et al., “Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969-1993.” (75) Inventors: Mike Tyers, Toronto (CA); Phedias Am. J. Epidemiol. 155(12): 1088-1095 (Jun. 15, 2002). Diamandis, Toronto (CA); Peter B. Dalton et al., “Risk for cancer in a cohort of patients hospitalized for Dirks, Toronto (CA) schizophrenia in Denmark, 1969-1993.” Schizophr. Res., 75(2- 3):315-324 (Jun. 15, 2005; e-pub: Dec. 13, 2004). (73) Assignees: HSC Research and Development Ding et al., “A role for chemistry in stem cell biology” Nat. Limited Partnership (CA); Mount Biotechnol. 22(7):833-840 (Jul 2004; e-pub: Jun. 30, 2004). Sinai Hospital (CA) Diamandis et al., "Chemical genetics reveals a complex functional ground state of neural stem cells' Nat. Chem. Biol. 3(5):268-273 (*) Notice: Subject to any disclaimer, the term of this (May 2007; e-pub: Apr. 8, 2007). patent is extended or adjusted under 35 Encinas et al., “Fluoxetine targets early progenitor cells in the adult brain” Proc. Natl. Acad. Sci. USA, 103(21):8233-8238 (May 23, U.S.C. 154(b) by 604 days. 2006; e-pub: May 15, 2006). Enver et al., “Loops, lineage, and leukemia' Cell, 94(1):9-12 (Jul. 10, (21) Appl. No.: 11/871,562 1998). Galanis et al., "Chemotherapy for high-grade gliomas' Br. J. Cancer, (22) Filed: Oct. 12, 2007 82(8): 1371-1380 (Apr. 2000). Galli et al., “Isolation and characterization of tumorigenic, stem-like (65) Prior Publication Data neural precursors from human glioblastoma Cancer Res., 64(19):701 1-7021 (Oct. 1, 2004). US 2009/0076O19 A1 Mar. 19, 2009 Ge et al., “GABA sets the tempo for activity-dependent adult neurogenesis' Trends Neurosci., 30(1): 1-8 (Jan. 2007; e-pub: Nov. Related U.S. Application Data 20, 2006). Goldacre et al., “Schizophrenia and cancer: an epidemiological (60) Provisional application No. 60/851,615, filed on Oct. study”. Br. J. Psychiatry, 187:334-338 (Oct. 2005). 13, 2006. Gritti et al., “Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like popula tion from the subventricular region of the adult mouse forebrain' J. (51) Int. Cl. Neurosci., 19(9):3287-3297 (May 1, 1999). A6IP35/00 (2006.01) Groszer et al., “PTEN negatively regulates neural stem cell self CI2N5/095 (2010.01) renewal by modulating Go-Gi cell cycle entry” Proc. Natl. Acad. Sci. (52) U.S. Cl. ....... 514/19.3; 435/377: 514/18.1; 558/483 USA, 103(1):111-116 (Jan. 3, 2006; e-pub: Dec. 22, 2005). (58) Field of Classification Search ........................ None Hagell et al., “Apomorphine in the treatment of Parkinson's disease” J. Neurosci. Nurs. 33(1): 21-34, 37-38 (Feb. 2001). See application file for complete search history. Hagg T., “Molecular regulation of adult CNS neurogenesis: an inte grated view” Trends Neurosci., 28(11): 589-95 (Nov. 2005; e-pub: (56) References Cited Sep. 8, 2005). Harrist et al., “Alteration of hippocampal cell proliferation in mice U.S. PATENT DOCUMENTS lacking the f2 subunit of the neuronal nicotinic acetylcholine recep 2005/0054650 A1 3f2005 Ikonomidou ................. 514,249 tor” Synapse, 54(4):200-206 (Dec. 15, 2004). Hemmati et al., “Cancerous stem cells can arise from pediatric brain OTHER PUBLICATIONS tumors” Proc. Natl. Acad. Sci. USA, 100(25): 15178-15183 (Dec. 9, 2003; e-pub: Nov. 26, 2003). Ohgaki et al., Cancer Science, 100(12): 2235-2241, Dec. 2009.* Hertz et al., “Receptor expression in primary cultures of neurons or Ahn et al., “In vivo analysis of quiescent adult neural stem cells astrocytes' Prog. Neuropsychopharmacol. Biol. Psychiatry, 8(4- responding to Sonic hedgehog' Nature, 437(3994):894-897 (Oct. 6):521-527 (1984). 2005). Hitoshi et al., “Notch pathway molecules are essential for the main Baker et al., “Dopaminergic nigrostriatal projections regulate neural tenance, but not the generation, of mammalian neural stem cells' precursor proliferation in the adult mouse subventricular Zone” Eur J Genes Dev., 16(7):846-58 (Apr. 1, 2002). Neurosci., 2002):575-579 (Jul 2004). Bao et al., "Glioma stem cells promote radioresistance by preferen (Continued) tial activation of the DNA damage response” Nature,444(7120):756 760 (Dec. 7, 2006; e-pub: Oct. 18, 2006). Primary Examiner — Lorraine Spector Barak et al., “Reduced cancer incidence among patients with Schizo Assistant Examiner — Stacey MacFarlane phrenia Cancer, 104(12):2817-2821 (Dec. 15, 2005). Burger et al., “Glioblastoma multiforme and anaplastic astrocytoma. (74) Attorney, Agent, or Firm — Howson & Howson LLP Pathologic criteria and prognostic implications' Cancer, 56(5): 1106 (57) ABSTRACT 1111 (Sep. 1, 1985). Berman et al., “Medulloblastoma growth inhibition by hedgehog A clonogenic neurosphere assay is described that carries out pathway blockade” Science, 297(5586): 1559-1561 (Aug. 30, 2002). high throughput screens (HTS) to identify potent and/or Carney et al., “Occurrence of cancer among people with mental selective modulators of proliferation, differentiation and/or health claims in an insured population” Psychosom Med., 66(5):735 743 (Sep.-Oct. 2004). renewal of neural precursor cells, neural progenitor cells and/ Chen et al., “Self-renewal of embryonic stem cells by a small mol or self-renewing and multipotent neural stem cells (NSCs). ecule” Proc. Natl. Acad. Sci. USA., 103(46): 17266-17271 (Nov. 14, Compositions comprising the identified modulators and 2006; e-pub Nov. 6, 2006). methods of using the modulators and compositions, in par Cohen et al., “Food and Drug Administration Drug approval Sum ticular to treat neurological disorders (e.g. brain or CNS can mary: temozolomide plus radiation therapy for the treatment of cer) or damage are also disclosed. newly diagnosed glioblastoma multiforme” Clin. Cancer Res., 11(19 pt 1):6767-6771 (Oct. 1, 2005). 4 Claims, 26 Drawing Sheets US 8,058,243 B2 Page 2 OTHER PUBLICATIONS Reynolds et al., “Clonal and population analyses demonstrate that an Höglinger et al., “Dopamine depletion impairs precursor cell prolif EGF-responsive mammalian embryonic CNS precursor is a stem eration in Parkinson disease” Nat. Neurosci., 7(7):726-735 (Jul. cell” Dev. Biol., 175(90): 1-13 (Apr. 10, 1996). 2004; e-pub Jun. 13, 2004). Reynolds et al., “Neural stem cells and neurospheres—re-evaluating Iacovelli et al., “Pharmacological activation of mGlu4 metabotropic the relationship'Nat. Methods, 2(5):333-336 (May 2005; e-pub: Apr. glutamate receptors inhibits the growth of medulloblastomas' J. 21, 2005). Neurosci., 26(32): 8388-8397 (Aug. 9, 2006). Santos et al., “Stemness:Transcriptional profiling of embryonic and Kevorkov et al., “Statistical analysis of systematic errors in high throughput screening” J. Biomol. Screen., 10(6):557-567 (Sep. 2005; adult stem cells' Science, 298(5593):597-600 (Oct. 18, 2002; e-pub: e-pub Aug. 15, 2005). Sep. 12, 2002). Kippin et al., “Dopamine specifically inhibits forebrain neural stem Santarelli et al., “Requirement of hippocampal neurogenesis for the cell proliferation, Suggesting a novel effect of antipsychotic drugs' J. behavioral effects of antidepressants' Science, 301(5634):805-809 Neurosci., 25(24):5815-5823 (Jun. 15, 2005). (Aug. 8, 2003). Lalonde et al., “Are dopamine antagonists a risk factor for breast Seifert et al., “Astrocyte dysfunction in neurological disorders: a cancer? An answer from Parkinson's disease' Breast, 12(4):280-282 molecular perspective” Nat. Rev. Neurosci., 7(3): 194-206 (Mar. (Aug. 2003). 2006). Lee et al., “Tumor stem cells derived from glioblastomas cultured in Sharomet al., “From large networks to small molecules' Curr. Opin. bFGF and EGF more closely mirror the phenotype and genotype of Chem. Biol. 8(1): 81-90 (Feb. 2004). primary tumors than do serum-cultured cell lines' Cancer Cell, Singh et al., “Identification of human brain tumour initiating cells' 9(5):391-403 (May 2006). Nature, 432: 396–401 (Nov. 18, 2004). Lie et al., “Wnt signalling regulates adult hippocampal Singh et al., “Identification of a cancer stem cell in human brain neurogenesis” Nature, 437:1370-1375 (Oct. 27, 2005). tumors' Cancer Res., 63(18):5821-5828 (Sep. 15, 2003). Lledo et al., “Adult neurogenesis and functional plasticity in neuronal circuits' Nat. Rev. Neurosci., 7(3): 179-193 (Mar. 2006). Taylor et al., “Radial glia cells are candidate stem cells of MacDonald et al., “Identifying off-target effects and hidden pheno ependymoma Cancer Cell, 8:323-335 (Oct. 17, 2005). types of drugs in human cells' Nat. Chem. Biol. 2(6):329-337 (Jun. Tropepe et al., “Distinct neural stem cells proliferate in response to 2006; e-pub: May 7, 2006). EGF and FGF in the developing mouse telencephalon” Dev. Biol. Molofsky et al., “Bmi-1 dependence distinguishes neural stem cell 208(1):166-188 (Apr. 1, 1999). self-renewal from progenitor proliferation” Nature, 425(6961): 962 Uchida et al., “Direct isolation of human central nervous system stem 967 (Oct. 30, 2003; e-pub: Oct. 22, 2003). cells' Proc. Natl. Acad. Sci. USA, 97(26): 14720-14725 (Dec. 19, Nacher et al., “NMDA receptor antagonist treatment increases the 2000). production of new neurons in the aged rathippocampus' Neurobiol. Vescoviet al., “Brain tumour stem cells' Nat. Rev. Cancer, 6(6);425 Aging, 24(2):273-284 (Mar.-Apr. 2003). 436 (Jun. 2006). Newlands et al., "Temozolomide: a review of its discovery, chemical Wishart et al., “DrugBank: a comprehensive resource for in silico properties, pre-clinical development and clinical trials' Cancer Treat drug discovery and exploration” Nucleic Acids Res., 34(Database Rev.